# Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

> **NCT06368102** · PHASE4 · COMPLETED · sponsor: **Uji Takeda Hospital** · enrollment: 70 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Ampicillin

## Key facts

- **NCT ID:** NCT06368102
- **Lead sponsor:** Uji Takeda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-02
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368102, "Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06368102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*